News
Larger absolute rivaroxaban benefit in diabetes: COMPASS
News
Adenoma detection rate removed from 2020 MIPS, or was it?
This article explains the joint effort made by all GI societies to try to save the Adenoma Detection Rate measure from removal from the 2020...
News
UK TAVI: Similar outcomes to surgery in real world
The trial confirms that the results of previous trials in low- to intermediate-risk patients can also be replicated in real-world clinical...
News
Vaginal artesunate quells CIN 2/3 lesions, clears HPV
Self-administered treatment with the antimalarial drug artesunate was safe and effective in a small proof-of-concept study.
Article
The Society of Hospital Medicine’s Commitment to Increasing Academic Representation for Women and Underrepresented Groups in Medicine: A Good Start
Article
Leadership & Professional Development: Evidence-Based Strategies to Make Team Meetings More Effective
Article
SPEAKers at the National Society of Hospital Medicine Meeting: A Follow-UP Study of Gender Equity for Conference Speakers from 2015 to 2019. The SPEAK UP Study
News
VICTORIA: Vericiguat seen as novel success in tough-to-treat, high-risk heart failure
The relative risk reduction was modest, but experts say the benefit in absolute terms was remarkable for already well-treated patients.
News
TAILOR-PCI: Clopidogrel genotyping trial narrowly misses endpoint
The trial missed its ambitious primary endpoint of a 50% reduction in cardiovascular events, but experts felt that it still should change practice...
News
More than one in three cardiologists burned out, many ready to bolt
“These are not great signals, I think they’re shocking, quite frankly,” one observer remarked.